Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy - Vahdat, L T; Garcia, A A; Vogel, C (Breast Cancer Res Treat, 2013)
et al.